Tandem Diabetes Care, Inc. Investment Owned, at Cost
Tandem Diabetes Care, Inc. (TNDM) had Investment Owned, at Cost of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes
us-gaap:InvestmentOwnedAtCost · last filed 2025-02-26
- 2024-12-31: Investment Owned, at Cost $0.00.
- 2024-09-30: Investment Owned, at Cost $30.40M.
- 2024-06-30: Investment Owned, at Cost $30.40M.
- 2024-03-31: Investment Owned, at Cost $10.10M.
| Period end | Investment Owned, at Cost |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2024-09-30 | $30.40M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $30.40M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $10.10M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $10.10M 10-K · filed 2025-02-26 |
| 2023-09-30 | $10.10M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $10.10M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $16.40M 10-K · filed 2024-02-21 |
| 2021-12-31 | $8.10M 10-Q · filed 2023-05-03 |
| 2021-06-30 | $8.10M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |